HES1 and ovarian cancer: In conclusion, Notch1-3, Jagged1 and Hes1 are more highly expressed in highly malignant ovarian cancers, and upregulation of Notch pathway component protein expression in ovarian cancer is associated with shortened overall and disease-free survival, especially in patients with advanced tumors.